Effect of cyclooxygenase inhibitors in the adhesion of tumor cells to endothelial cells.
Papadimitriou
M N
MN
Rice University, Cox Laboratory for Biomedical Engineering, Institute of Biosciences and Bioengineering, Houston, TX 77005-1892, USA.
McIntire
L V
LV
Menter
D G
DG
D000818:Animals; D002448:Cell Adhesion / Q000187:drug effects*; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology*; D004727:Endothelium / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D007213:Indomethacin / Q000494:pharmacology; D016023:Integrins / Q000187:drug effects / Q000378:metabolism; D008223:Lymphoma / Q000188:drug therapy / Q000473:pathology; D051379:Mice; D009578:Nitrobenzenes / Q000494:pharmacology; D013449:Sulfonamides / Q000494:pharmacology; D013467:Sulindac / Q000494:pharmacology; D014407:Tumor Cells, Cultured / Q000187:drug effects*; D019010:Vascular Cell Adhesion Molecule-1 / Q000187:drug effects / Q000378:metabolism
D016861:Cyclooxygenase Inhibitors; D016023:Integrins; D009578:Nitrobenzenes; D013449:Sulfonamides; D019010:Vascular Cell Adhesion Molecule-1; C080955:N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide; D013467:Sulindac; D007213:Indomethacin